KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Goodwill (2016 - 2025)

Astrazeneca (AZN) has 3 years of Goodwill data on record, last reported at $21.2 billion in Q4 2025.

  • For Q4 2025, Goodwill rose 1.03% year-over-year to $21.2 billion; the TTM value through Dec 2025 reached $21.2 billion, up 1.03%, while the annual FY2025 figure was $21.2 billion, 1.03% up from the prior year.
  • Goodwill reached $21.2 billion in Q4 2025 per AZN's latest filing, up from $21.0 billion in the prior quarter.
  • Across five years, Goodwill topped out at $21.2 billion in Q4 2025 and bottomed at -$313.0 million in Q4 2023.
  • Average Goodwill over 3 years is $14.0 billion, with a median of $21.0 billion recorded in 2024.
  • Peak YoY movement for Goodwill: skyrocketed 6817.25% in 2024, then grew 1.03% in 2025.
  • A 3-year view of Goodwill shows it stood at -$313.0 million in 2023, then surged by 6817.25% to $21.0 billion in 2024, then grew by 1.03% to $21.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill were $21.2 billion in Q4 2025, $21.0 billion in Q4 2024, and -$313.0 million in Q4 2023.